共 13 条
- [3] Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature [J]. CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 30 - 35
- [4] The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor [J]. THERANOSTICS, 2020, 10 (03): : 1107 - 1121